ICOSAVAX, INC. Additional Paid in Capital
ICOSAVAX, INC. had Additional Paid in Capital of $491.35 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2023-11-14
- 2023-09-30: Additional Paid in Capital $491.35M.
- 2023-06-30: Additional Paid in Capital $484.67M.
- 2023-03-31: Additional Paid in Capital $410.53M.
- 2022-12-31: Additional Paid in Capital $404.39M.
| Period end | Additional Paid in Capital |
|---|---|
| 2023-09-30 | $491.35M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $484.67M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $410.53M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $404.39M 10-Q · filed 2023-11-14 |
| 2022-09-30 | $388.48M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $382.94M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $377.14M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $372.28M 10-K · filed 2023-03-30 |
| 2021-09-30 | $368.32M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.20M 10-Q · filed 2021-09-13 |
| 2020-12-31 | $393.00K 10-K · filed 2022-03-30 |